StockGlow

Avalyn Pharma Inc. (AVLN)

Avalyn Pharma Inc.

$28.20-0.04%Healthcare
Compare AVLN with
StockGlow Score
40
Neutral
BearishBullish
1 year ago-5.5%

The outlook

Avalyn Pharma Inc. currently reads as neutral based on below its 50- & 200-day averages, 44% of the way from its 52-week low to high, avg target +109% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range44% of the way from its 52-week low to high
Price targetAvg target +109% vs current price

Analyst price target

~12-month · 4 analysts
$59.00average target+109.3% vs now
Now $28.20
Low $51.00High $80.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$1.25B
52-wk high
$33.32
52-wk low
$24.15
50-day avg
$28.66
200-day avg
$28.70
Trailing P/E
—

Similar stocks

COAGHemab Therapeutics Holdings, Inc.$46.38-2.30%SPTXSeaport Therapeutics, Inc.$20.03-1.45%KLRAKailera Therapeutics, Inc.$16.78-1.58%ODTXOdyssey Therapeutics, Inc.$18.34-0.43%AGMBAgomAb Therapeutics NV$12.58-1.37%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy